Wellstif Tablet is a combination analgesic formulation containing Aceclofenac (100mg), Paracetamol (325mg), and Tizanidine (2mg), designed to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. Tizanidine, a centrally acting muscle relaxant, helps alleviate muscle spasticity by blocking nerve impulses and reducing muscle tone. The synergistic action of these three components makes Wellstif Tablet particularly useful in managing conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal injuries. It is recommended to be taken under medical supervision, with caution in patients with hepatic, renal, or cardiovascular impairments. Common side effects may include gastrointestinal discomfort, dizziness, and drowsiness. Wellstif Tablet should be used at the prescribed dose to minimize adverse effects and maximize therapeutic benefits. It is contraindicated in individuals with hypersensitivity to any of its components or history of peptic ulcer disease.